DOI QR코드

DOI QR Code

DRG2 Regulates G2/M Progression via the Cyclin B1-Cdk1 Complex

  • Jang, Soo Hwa (School of Biological Sciences, University of Ulsan) ;
  • Kim, Ah-Ram (School of Biological Sciences, University of Ulsan) ;
  • Park, Neung-Hwa (Department of Internal Medicine, University of Ulsan College of Medicine, Ulsan University Hospital) ;
  • Park, Jeong Woo (School of Biological Sciences, University of Ulsan) ;
  • Han, In-Seob (School of Biological Sciences, University of Ulsan)
  • Received : 2016.06.14
  • Accepted : 2016.08.25
  • Published : 2016.09.30

Abstract

Developmentally regulated GTP-binding protein 2 (DRG2) plays an important role in cell growth. Here we explored the linkage between DRG2 and G2/M phase checkpoint function in cell cycle progression. We observed that knockdown of DRG2 in HeLa cells affected growth in a wound-healing assay, and tumorigenicity in nude mice xenografts. Flow cytometry assays and [$^3H$] incorporation assays indicated that G2/M phase arrest was responsible for the decreased proliferation of these cells. Knockdown of DRG2 elicited down-regulation of the major mitotic promoting factor, the cyclin B1/Cdk1 complex, but upregulation of the cell cycle arresting proteins, Wee1, Myt1, and p21. These findings identify a novel role of DRG2 in G2/M progression.

Keywords

References

  1. Baldin, V., and Ducommun, B. (1995). Subcellular localisation of human wee1 kinase is regulated during the cell cycle. J. Cell Sci. 108( Pt 6), 2425-2432.
  2. Besson, A., Dowdy, S.F., and Roberts, J.M. (2008). CDK inhibitors:cell cycle regulators and beyond. Dev. Cell 14, 159-169. https://doi.org/10.1016/j.devcel.2008.01.013
  3. Cazzalini, O., Scovassi, A.I., Savio, M., Stivala, L.A., and Prosperi, E. (2010). Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat. Res. 704, 12-20. https://doi.org/10.1016/j.mrrev.2010.01.009
  4. Charrier-Savournin, F.B., Chateau, M.T., Gire, V., Sedivy, J., Piette, J., and Dulic, V. (2004). p21-Mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress. Mol. Biol Cell. 15, 3965-3976. https://doi.org/10.1091/mbc.E03-12-0871
  5. Fisher, D., Krasinska, L., Coudreuse, D., and Novak, B. (2012). Phosphorylation network dynamics in the control of cell cycle transitions. J. Cell Sci. 125, 4703-4711. https://doi.org/10.1242/jcs.106351
  6. Gavet, O., and Pines, J. (2010). Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev. Cell 18, 533-543. https://doi.org/10.1016/j.devcel.2010.02.013
  7. Ko, M.S., Lee, U.H., Kim, S.I., Kim, H.J., Park, J.J., Cha, S.J., Kim, S.B., Song, H., Chung, D.K., Han, I.S., et al. (2004). Overexpression of DRG2 suppresses the growth of Jurkat T cells but does not induce apoptosis. Arch. Biochem. Biophys. 422, 137-144. https://doi.org/10.1016/j.abb.2003.12.028
  8. Kreis, N.N., Sanhaji, M., Rieger, M.A., Louwen, F., and Yuan, J. (2014). p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells. Oncogene 33, 5716-5728. https://doi.org/10.1038/onc.2013.518
  9. Kreis, N.N., Louwen, F., and Yuan, J. (2015). Less understood issues: p21 in mitosis and its therapeutic potential. Oncogene 34, 1758-1767. https://doi.org/10.1038/onc.2014.133
  10. Lindqvist, A., Rodriguez-Bravo, V., and Medema, R.H. (2009). The decision to enter mitosis: feedback and redundancy in the mitotic entry network. J. Cell Biol. 185, 193-202. https://doi.org/10.1083/jcb.200812045
  11. Mani, M., Lee, U.H., Yoon, N.A., Kim, H.J., Ko, M.S., Seol, W., Joe, Y., Chung, H.T., Lee, B.J., Moon, C.H., et al. (2016). Developmentally regulated GTP-binding protein 2 coordinates Rab5 activity and transferrin recycling. Mol. Biol Cell. 27, 334-348. https://doi.org/10.1091/mbc.E15-08-0558
  12. Masuda, H., Fong, C.S., Ohtsuki, C., Haraguchi, T., and Hiraoka, Y. (2011). Spatiotemporal regulations of Wee1 at the G2/M transition. Mol. Biol Cell. 22, 555-569. https://doi.org/10.1091/mbc.E10-07-0644
  13. Oh, J.S., Han, S.J., and Conti, M. (2010). Wee1B, Myt1, and Cdc25 function in distinct compartments of the mouse oocyte to control meiotic resumption. J. Cell Biol. 188, 199-207. https://doi.org/10.1083/jcb.200907161
  14. Song, H., Kim, S.I., Ko, M.S., Kim, H.J., Heo, J.C., Lee, H.J., Lee, H.S., Han, I.S., Kwack, K., and Park, J.W. (2004). Overexpression of DRG2 increases G2/M phase cells and decreases sensitivity to nocodazole-induced apoptosis. J. Biochem. 135, 331-335. https://doi.org/10.1093/jb/mvh040

Cited by

  1. HBXIP, a binding protein of HBx, regulates maintenance of the G2/M phase checkpoint induced by DNA damage and enhances sensitivity to doxorubicin-induced cytotoxicity vol.16, pp.5, 2017, https://doi.org/10.1080/15384101.2017.1281482
  2. Targeting inhibitors of apoptosis proteins suppresses medulloblastoma cell proliferation via G2/M phase arrest and attenuated neddylation of p21 vol.7, pp.8, 2018, https://doi.org/10.1002/cam4.1658
  3. The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases vol.14, pp.7, 2018, https://doi.org/10.1038/s41589-018-0071-y
  4. Cell division cycle associated 5 promotes colorectal cancer progression by activating the ERK signaling pathway vol.8, pp.3, 2019, https://doi.org/10.1038/s41389-019-0123-5
  5. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer vol.8, pp.28, 2016, https://doi.org/10.18632/oncotarget.17564
  6. Functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early‐stage non‐small‐cell lung cancer vol.109, pp.12, 2018, https://doi.org/10.1111/cas.13814
  7. DRG2 Deficiency Causes Impaired Microtubule Dynamics in HeLa Cells vol.41, pp.12, 2016, https://doi.org/10.14348/molcells.2018.0129
  8. 6,7-Dihydroxy-2-(4′-hydroxyphenyl)naphthalene induces HCT116 cell apoptosis through activation of endoplasmic reticulum stress and the extrinsic apoptotic pathway vol.13, pp.None, 2016, https://doi.org/10.2147/dddt.s193914
  9. Lycopene upregulates ZO-1 and downregulates claudin-1 through autophagy inhibition in the human cutaneous squamous cell carcinoma cell line COLO-16 vol.10, pp.2, 2019, https://doi.org/10.7150/jca.26578
  10. Predicting chromosome 1p/19q codeletion by RNA expression profile: a comparison of current prediction models vol.11, pp.3, 2016, https://doi.org/10.18632/aging.101795
  11. Camptothecin induces mitotic arrest through Mad2-Cdc20 complex by activating the JNK-mediated Sp1 pathway vol.127, pp.None, 2019, https://doi.org/10.1016/j.fct.2019.03.026
  12. Downregulation of lncRNA AFAP1-AS1 by oridonin inhibits the epithelial-to-mesenchymal transition and proliferation of pancreatic cancer cells vol.51, pp.8, 2019, https://doi.org/10.1093/abbs/gmz071
  13. DRG2 Deficient Mice Exhibit Impaired Motor Behaviors with Reduced Striatal Dopamine Release vol.21, pp.1, 2016, https://doi.org/10.3390/ijms21010060
  14. Ribosome binding protein GCN1 regulates the cell cycle and cell proliferation and is essential for the embryonic development of mice vol.16, pp.4, 2020, https://doi.org/10.1371/journal.pgen.1008693
  15. DRG2 supports the growth of primary tumors and metastases of melanoma by enhancing VEGF‐A expression vol.287, pp.10, 2020, https://doi.org/10.1111/febs.15125
  16. Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth vol.34, pp.8, 2020, https://doi.org/10.1002/ptr.6661
  17. High-throughput sequencing-based analysis of gene expression of hepatitis B virus infection-associated human hepatocellular carcinoma vol.20, pp.4, 2020, https://doi.org/10.3892/ol.2020.11879
  18. EMI2 expression as a poor prognostic factor in patients with breast cancer vol.36, pp.8, 2020, https://doi.org/10.1002/kjm2.12208
  19. The Proteomic Landscape of Resting and Activated CD4+ T Cells Reveal Insights into Cell Differentiation and Function vol.22, pp.1, 2016, https://doi.org/10.3390/ijms22010275
  20. DRG2 Accelerates Senescence via Negative Regulation of SIRT1 in Human Diploid Fibroblasts vol.2021, pp.None, 2021, https://doi.org/10.1155/2021/7301373
  21. Tumor suppressive role of mitochondrial sirtuin 4 in induction of G2/M cell cycle arrest and apoptosis in hepatitis B virus-related hepatocellular carcinoma vol.7, pp.1, 2016, https://doi.org/10.1038/s41420-021-00470-8
  22. A Natural Degradant of Curcumin, Feruloylacetone Inhibits Cell Proliferation via Inducing Cell Cycle Arrest and a Mitochondrial Apoptotic Pathway in HCT116 Colon Cancer Cells vol.26, pp.16, 2016, https://doi.org/10.3390/molecules26164884
  23. Lanatoside C inhibits human cervical cancer cell proliferation and induces cell apoptosis by a reduction of the JAK2/STAT6/SOCS2 signaling pathway vol.22, pp.4, 2016, https://doi.org/10.3892/ol.2021.13001
  24. Developmentally regulated GTPases: structure, function and roles in disease vol.78, pp.23, 2016, https://doi.org/10.1007/s00018-021-03961-0
  25. YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis vol.21, pp.1, 2021, https://doi.org/10.1186/s12935-021-02328-6
  26. Janerin Induces Cell Cycle Arrest at the G2/M Phase and Promotes Apoptosis Involving the MAPK Pathway in THP-1, Leukemic Cell Line vol.26, pp.24, 2016, https://doi.org/10.3390/molecules26247555